Press Releases
Keyword Search
09.06.22
OpGen Announces Participation at the H.C. Wainwright 24th Annual Global Investment Conference
08.31.22
Nasdaq Grants OpGen 180-Day Extension to Meet Minimum Bid Price Requirement
08.25.22
OpGen Launches Ares Sequencing Services in the U.S. from its Rockville, Maryland Laboratory
08.11.22
OpGen Reports Second Quarter 2022 Financial Results and Provides Business Update
07.28.22
OpGen to Provide Business Update and Financial Results for the Second Quarter 2022 on August 11th at 4:30 p.m. Eastern Time
07.26.22
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
07.08.22
OpGen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 and Provides Business Update
06.22.22
OpGen Announces Publication of Results of Unyvero Hospitalized Pneumonia (HPN) Panel for Detection of Bacterial Respiratory Tract Pathogens from Serial Specimens Collected from Hospitalized COVID-19 Patients
06.22.22
OpGen Announces 1,000th Patient Sample Enrolled in Clinical Trial for Unyvero Urinary Tract Infection Panel
06.09.22
OpGen Subsidiary Curetis and Leader Life Sciences Enter into Unyvero Distribution Partnership for U.A.E. and Qatar